Real-life efficacy and safety of patients treated with ixazomib in combination with lenalidomide and dexamethasone, for relapsed and/or refractory multiple myeloma: a prospective, non-interventional, real-life study (REMIX) | HMA-EMA Catalogues of real-world data sources and studies